Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence

Key Points

• The study aims to evaluate the role of glutamine and methionine dependence as vulnerabilities in cancer therapy.
• Comparison of glutamine dependence (GR) and methionine dependence (MR) in various contexts.
• Assessment of GR and MR as potential cancer therapy strategies.
• Glutamine dependence (GR) is not specific to cancer.
• Methionine dependence (MR) shows potential as a cancer-specific vulnerability.